Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Chronic myeloid leukemia in the imatinib era
Brian J. Druker
Knight Cancer Institute
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Chronic myeloid leukemia in the imatinib era'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Imatinib Mesylate
100%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
92%
Therapeutics
2%